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The recent paper “Multimodal imaging demonstrates concomitant changes in
bone and cartilage after destabilization of the medial meniscus and increased
joint laxity”The recent paper “Multimodal imaging demonstrates concomi-
tant changes in bone and cartilage after destabilization of the medial
meniscus and increased joint laxity”1, explores an important issue
i.e., the relationship between cartilage and bone pathology, and
the role of joint laxity in post-traumatic osteoarthritis (OA).
However, there are several concerns as to whether the model used
was indeed the medial meniscal destabilization (DMM) model, and
therefore whether the conclusions drawn are valid. In light of the
widespread use of different surgical models of OA in a variety of
species including mice, recent steps towards standardization of
histological outcome measures have been made to enable better
comparison between different studies2,3. Our concerns with the
current paper (as outlined below) are a timely reminder that stan-
dardization and validation of the procedures/methods used to
induce OA is also necessary and critical to facilitate comparative
evaluation betweenpublications involving different research groups.
In the current paper, analysis of joints immediately following
(what is described as DMM) surgery, revealed an increase (albeit
withmarked variance) in anterior and posterior tibial displacement.
The authors conclude that: “DMM surgery caused a signiﬁcant
increase of tibial anterior-posterior (AP) range of motion, particu-
larly with the tibia moving in an anterior direction with respect to
the femur”. In separate groups of mice at 4 and 8 weeks after
DMMsurgery, the bone and cartilagepathologywas examinedusing
mCT and inverted confocal laser microscopy. In 13/23 specimens
(6/11 at 4 weeks and 8/12 at 8 weeks after surgery), marked
posterior medial tibial plateau erosion (at times down to or through
the growth plate) was observed, while this was not apparent in the
remaining animals.
The inconsistent joint laxity and pathology (particularly the
posterior tibial bone erosion) may be explained by a highly variable
induction of instability, and are consistentwith inadvertent anterior
cruciate ligament (ACL) transection in a proportion of mice. The
authors did discuss the possibility that their data “.may be a result
of surgery affecting the ACL to different extents”. As published with
both surgical (129/SvEv4 and C57BL/65) and enzymatic6 methods,
loss of ACL integrity inmice causes signiﬁcant AP laxity, andmarked
posterior tibial bone erosion. In contrast, it is our combined experi-
ence that nomanually discernable anterior drawer is observed after
validated DMM surgery where no ACL injury occurs. Most impor-
tantly, in no cases have we seen the marked posterior tibial bone
erosion as described in the current study following DMM, even
when mice are maintained for 4–6 months post-surgery7–14.
Indeed, the DMM model, far from showing tibial bone erosion, is
typiﬁed by increased subchondral bone formation7.1063-4584/$ – see front matter Crown Copyright  2011 Published by Elsevier Ltd on b
doi:10.1016/j.joca.2011.04.018The authors considered it “. conceivable that during meniscal
transection, damage is done to the ACL”. Unfortunately, no gross
or histological examination was undertaken either immediately,
or at the 4 or 8 weeks post-surgery time points in the current study,
to conﬁrm the presence or absence of ACL injury. Such damage can
be readily identiﬁed in serial coronal (and sagittal) sections4. No
biomechanical or histological evaluation of the joints was con-
ducted, and therefore a correlation between AP laxity, the severity
of joint pathology and ACL integrity could not be made.
Mouse strain is proposed as a possible reason for the discrepancy
between the observed pathology and that reported in the literature.
However, previous studies, not cited in the current paper11,12, have
used C57BL/6 mice in the DMM model and did not observe the
extensive posterior bone erosion reported here. The location of
the pathology in the DMM model is consistently in the mid-
anterior region of the tibial plateau in over 12 different strains inves-
tigated includingC57BL/64,7–14, andnot in theposterioraspect of the
joint reported in the Moodie paper. While a difference in absolute
severity of histologic OA can be seen with different strains14, the
location of the pathology does not appear to change appreciably.
Moodie et al. also suggest that assessment technique may also
contribute to the discrepancy stating that “coronal histologic
section in mid-plateau may overlook the loss occurring in the
posterior region”. It should be clariﬁed that the published coronal
histologic sections we have performed4,7–10 and that are recom-
mended in the OARSI guidelines3, utilize serial sections through
the depth of the entire joint encompassing the posterior tibial
plateau, so that overlooking of posterior erosions is not possible.
Furthermore, in several studies11–13 sagittal rather than coronal
sections have been used, with no reports of the severe posterior
tibial erosion described in the present paper.
Animal models, and particularly recent studies using
genetically-modiﬁed mice, have added signiﬁcantly to our under-
standing of the pathophysiology and potential treatment of OA. In
this regard the question addressed in the current study by Moodie
et al. regarding global joint pathology and the interaction between
different tissues is important, and can only be appropriately
addressed with in vivo studies. However, as recently highlighted15,
many of the published studies utilizing animal models have report-
ing deﬁciencies that make subsequent systematic reviews of the
literature difﬁcult, if not impossible. One such issue, that is critical
to such systematic review, is appropriate validation of the animal
model used. The purpose of our letter therefore is not to contest
the data presented in the current paper, but rather to suggest
that it may represent a mixture of two models that have quiteehalf of Osteoarthritis Research Society International. All rights reserved.
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DMMACL deﬁciency. Appropriate validation such as gross and
ideally histological examination of the ACL would have not only
resolved this issue but also potentially allowed subsequent stratiﬁ-
cation of the outcomes into the two models. It would also
strengthen the power of conclusions despite the reduced “n” in
each group, by reducing the variance which may well be OA-
model related. Greater investments in validating a model for each
research group, and indeed each surgeon within a group, and/or
collaborating where the time investment cannot be made, will
ensure the correct application of animal models, limit the need to
replicate animal studies, and enhance our ability to conduct
systematic reviews of the literature.
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